MedTrace Logo

Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK

NCT00347204 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2006-07-04

No results posted yet for this study

Summary

To determine the ability of two topical Nonsteroidal Anti-inflammatory drops (Acular LS \& Nevanac) to help control pain following Photorefractive Keratectomy (PRK).

Conditions

  • Myopia
  • Hyperopia

Interventions

DRUG

ketorolac (Acular LS)

DRUG

Nepafenac (Nevanac)

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Center For Excellence In Eye Care

    lead OTHER

Principal Investigators

  • William Trattler, MD · Center For Excellence In Eye Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-01-31
Completion
2006-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347204 on ClinicalTrials.gov